Renee P. Tannenbaum
At a glance: Renee P. Tannenbaum is Director at Ani Pharmaceuticals (ANIP). Their latest SEC Form 4, filed Dec 9, 2025, reported a sale of $146K. On file: 0 purchase lines ($0) and 1 sale line ($146K).
Disclosed holdings: about $1.7M of ANIP stock: 25,157 shares reported on their latest Form 4 (filed Dec 9, 2025), valued at the Nov 20, 2026 close of $69.11. This counts only ANIP shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Ani Pharmaceuticals Inc (ANIP)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Renee P. Tannenbaum's InsiderPrint
4 trades from SEC Form 4 filings, 2021 to 2025, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $85K a trade.
- Bump outward: a purchase (3)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Eric EtchartDirector · GGG · 100% match
- Justin KassPm · ACV · 100% match
- David J. LeeDirector · ZVIA · 99% match
- Devin Ignatius MurphyDirector · CXW · 99% match
- Dennis V. ArriolaDirector · CMC · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2024
From the SEC's insider data sets: each open-market buy by Renee P. Tannenbaum, matched to how the stock did over the next 90 days against the S&P 500.
0 of 1 buy beat the S&P 500 (0%), median -11.6% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| CRDF | Dec 18, 2024 | -11.6% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
Follow Renee P. Tannenbaum
Get one email when Renee P. Tannenbaum files a new purchase or sale. Free.
At most one email a day about Renee P. Tannenbaum, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.